- Email: [email protected]
Keyword index to volume 109
European Journal of Pharmacology, 109 (1985) 455-457
455
Elsevier
KEYWORD
INDEX TO VOLUME
Acetylcholinesterase Action potentials Adenosine Aden.osine triphosphate Adrenal catecholamine release Adrenergic blockade Adrenergic a2-receptor blockade Adrenergic receptors fl2-Adrenoceptor down-regulation a-Adrenoceptors a 1-Adrenoceptors fl-Adrenoceptors Agonist affinity Amfonelic acid 4-Aminopyridine cAMP Amphetamine d-Amphetamine Amphetamine-induced behaviour Amylase secretion Analgesia Anaphylaxis Anesthetics Antidepressants Antihypertensive Antihypertensive drugs Antipsychotic drugs Anti-VIP serum Apomorphine Atria Atypical neuroleptics Baroreceptors Benzodiazepine receptors Benzodiazepines Blood pressure Brain methadone concentration Bremazocine Brotizolam Bullfrog sympathetic ganglions Butoxamine -t-Butyrolactone Ca 2 + Calcium Cannabimimetics Cardiac output Cardiac output distribution Caudate nucleus Cerebral cortex
109
109 (1985) 91 109(1985) 219 109(1985) 373 109(1985) 373 109(1985) 1 109(1985) 9 109(1985) 153 109(1985) 327 109 (1985)401 109(1985) 173,289 109 (1985) 285 109(1985) 65 109 (1985) 389 109(1985) 73 109 (1985) 373 109(1985) 275 109 (1985) 81 109(1985) 395 109(1985) 81 109(1985) 355 109 (1985) 55,201 109(1985) 183 109(1985) 105 109 (1985) 97 109 (1985) 9 109(1985) 111 109(1985) 81 109 (1985)409 109(1985) 269, 349 109(1985) 65 109 (1985) 81 109 (1985) 105 109(1985) 19 109(1985) 363 109(1985)91,111,289 109(1985) 55 109(1985) 49 109(1985) 19 109(1985) 213 109(1985)413 109(1985) 229 109(1985) 213 109 (1985) 161, 335 109 (1985)201 109(1985) 173,263 109(1985)263 109(1985) 341 109(1985) 285
Chlorpromazine Chronic haloperidol Clone 235 - 1 Clonidine Classical neuroleptics Compound 48/'80 Conscious rats Convulsions Corpus striatum Cross tolerance CV-3988 CV-4151 Cyclic AMP Cyclic GMP
109 (1985) 193 109 (1985) 389 109 (1985) 335 109 (1985) 111 109 (1985) 81 109 (1985) 249 109 (1985) 9 109 (1985) 363 109 (1985) 417 109 (1985) 55 109 (1985) 257 109 (1985) 135 109 (1985) 335 109 (1985) 241
D-1 receptors 109 (1985) 269, 349 D-2 receptors 109 (1985) 269, 417 Dazoxiben 109 (1985) 117 Depression 109 (1985) 91 Diazepam 109 (1985) 241 Dihydro-fl-carboline 109 (1985) 363 Diuretic therapy 109 (1985) 401 DMSO 109 (1985) 213 Dobutamine 109 (1985) 173 Dogs 109 (1985) 49 Dopamine 109 (1985) 173, 341,355, 395, 417 Dopamine agonists 109 (1985) 229 Dopamine fl-hydroxylase inhibitors 109 (1985) 1 Dopamine metabolism 109 (1985) 229, 297 Dopamine receptor blockers 109 (1985) 269 Dopamine receptors 109 (1985) 297, 349, 389 Duodenal motility 109 (1985) 43 Electrical stimulation Electrochemistry (in vivo) Enantiomers Endotoxin shock Ethanol withdrawal Ethylketocylazocine
109(1985) 341 109(1985) 341 109(1985) 173 109 (1985) 257 109(1985) 321 109 (1985) 49
[3 H]Flunitrazepam binding Fluphenazine Fusaric acid
109(1985) 201 109(1985) 193 109(1985) 1
GABA Gastric Gastric Gastric Gastric Gastric
cytoprotection mucosal barrier mucosal defensive systems mucus ulcer
109 (1985) 19, 321 109 (1985) 145 109 (1985) 145 109 (1985) 145 109 (1985) 145 109 (1985) 145
456 GTP Guinea-pig lung Guinea-pigs
109(1985) 417 109(1985) 413 109(1985) 219,373
Harmalan Harmaline Heart failure Hematocrit Hemodynamics Hetrazepines 5-HIAA Hippocampal slices Histamine Hi-receptors 5-HT 5-HT uptake a-Human atrial natriuretic polypeptide (a-hANP) 6-Hydroxydopamine 3-(2-Hydroxyphenyl)cyclohexanols 5-Hydroxytryptamine release 5-Hydroxytryptophan (5-HTP) Hypertension Hypotension Hypovolemia
109(1985) 363 109(1985)241 109 (1985) 173, 405 109(1985) 249 109(1985) 173 109(1985) 19 109(1985) 381 109(1985) 395 109(1985) 249 !09 (1985) 381 109 (1985) 97 109(1985) 301,405 109(1985) 263 109 (1985) 201 109(1985) 395 109(1985) 409 109(1985) 111 109(1985) 301 109(1985) 249
Idazoxan lmidazole lmipramine Indoramin Infarct size Inositol phospholipids Intrarenal blood flow Iron deficiency Isoproterenol
109(1985) 153 109(1985) 117 109(1985) 97 109(1985) 9 109(1985) 117 109(1985) 293 109(1985) 301 109(1985) 193 109(1985)413
Ketanserin
109(1985) 363
Leukotriene C 4 Leukotriene D 4 Leukotriene E 4 Leukotriene receptors Levonantradol LSD binding Lung cells (momodispersed) Lung mast cells (purified) LY 171555 pergolide
109(1985) 183 109(1985) 183 109(1985) 183 109(1985) 183 109(1985) 201 109(1985)421 109(1985) 413 109(1985) 413 109(1985) 297
Magnesium Maitotoxin MAOI Median forebrain bundle Metabolism Methadone Methamphetamine Methyl-,8-carboline-3-carboxylate N-Methyl,N-propargyl-2-aminotetralins
109(1985)417 109(1985) 335 109(1985) 229,381 109(1985) 341 109(1985) 161 109(1985) 55 109(1985) 73 109 (1985)241 109(1985) 229
Metoclopramide Microtubules Monensin Morphine Muscarinic cholinergic agonists Muscarinic cholinergic receptors
109(1985) 81 109(1985) 161 109(1985) 161 109 (1985) 55 109(1985)293 109(1985) 161
Neurokinin A Neuropeptide Y Nifedipine [3H]NPA binding (in vitro) Nucleus tractus solitarii
109(1985) 109(1985) 109(1985) 109(1985) 109(1985)
Opiate receptor binding Opioid antagonists Opioid receptors x Opioid receptors Opioids
121 289 289 229 111
109(1985) 33 109(1985) 43 109(1985) 43,281 109(1985) 49 109(1985) 43
PAF-acether Pancreas Papillary muscles Paraventricular nucleus Parotid gland Pergolide PGI 2 Phencyclidine Physostigmine Pindolol Plasma extravasation Plasma renin activity Platelet activating factor (PAF) Platelets Postsynaptic [ 3H]Prazosin binding Preganglionic sympathetic nerve activity Presynaptic Progabide Prolactin Prolactin receptors Propranolol Purification
109(1985) 153 109(1985) 355 109 (1985) 321 109(1985) 193,335,409 109(1985) 193 109(1985) 117 109(1985) 97
Rat aorta Rat brain regions Rats Receptor regulation K Receptors Receptors Receptors (a, #, •, 8) Regional blood flow Release Repetitive firing Reserpine Reserpine reversal Ro 15-1788
109(1985) 275 109(1985) 421 109(1985) 105,173,405 109(1985) 183 109(1985) 281 109(1985) 281 109(1985) 33 109 (1985)301 109(1985) 381 109(1985) 213 109 (1985) 117, 381 109(1985) 229 109 (1985)241
109(1985) 219 109(1985) 293 109(1985) 219 109(1985) 9 109(1985) 355 109(1985) 349 109(1985) 135 109(1985) 33 109(1985) 91 109(1985) 65 109(1985) 249 109(1985) 249 109(1985) 257 109(1985) 91 109(1985) 355 109(1985) 285
457 Rotational behaviour SCH 23390 Sedation Serotonin Serotonin receptors SHR SKF 38393 Sleep Small intestinal motility Smooth muscle Smooth muscle relaxation Spiperone [ 3H]Spiperone Spontaneously hypertensive rats SRS-A Stereotypy Substance P Substance P antagonists Sulfonterol Sulpiride Supersensitivity Sympathetic transmission Sympathoexcitation Sympathomimetic effects Synaptic facilitation
109 (1985)349 109(1985) 269,349 109(1985) 269 109 (1985)91,409 109(1985) 421 109 (1985)301 109(1985) 297 109 (1985)269 109(1985 ) 49 109 (1985)161,327 109 (1985)275 109(1985)297 109 (1985) 417 109 (1985) 135 109 (1985) 183 109 (1985) 81,229 109(1985) 327 109(1985) 121 109(1985) 413 109(1985) 81 109(1985) 389 109(1985) 289 109(1985) 153 109(1985) 65 109(1985) 213
Tachykinins Taenia caeci Testosterone z~9-Tetrahydrocannabinol Thromboxane A 2 Thromboxane A 2 synthetase inhibitors Transmission Tryptamine
109(1985) 327 109(1985) 373 109 (1985) 193 109(1985)201 109 (1985) 135
U-50,488H Urinary bladder Uterus
109(1985) 49 109(1985) 327 109(1985) 65
Vasoactive intestinal polypeptide (VI P) Vasopressin
109(1985) 135 109(1985) 213 109 (1985)363
109 (1985)275,409 109 (1985) 111
WB 4101 Wy 26392
109(1985)285 109 (1985) 153
Yohimbine
109(1985) 153
Zinc salts
109(1985) 145
455
Elsevier
KEYWORD
INDEX TO VOLUME
Acetylcholinesterase Action potentials Adenosine Aden.osine triphosphate Adrenal catecholamine release Adrenergic blockade Adrenergic a2-receptor blockade Adrenergic receptors fl2-Adrenoceptor down-regulation a-Adrenoceptors a 1-Adrenoceptors fl-Adrenoceptors Agonist affinity Amfonelic acid 4-Aminopyridine cAMP Amphetamine d-Amphetamine Amphetamine-induced behaviour Amylase secretion Analgesia Anaphylaxis Anesthetics Antidepressants Antihypertensive Antihypertensive drugs Antipsychotic drugs Anti-VIP serum Apomorphine Atria Atypical neuroleptics Baroreceptors Benzodiazepine receptors Benzodiazepines Blood pressure Brain methadone concentration Bremazocine Brotizolam Bullfrog sympathetic ganglions Butoxamine -t-Butyrolactone Ca 2 + Calcium Cannabimimetics Cardiac output Cardiac output distribution Caudate nucleus Cerebral cortex
109
109 (1985) 91 109(1985) 219 109(1985) 373 109(1985) 373 109(1985) 1 109(1985) 9 109(1985) 153 109(1985) 327 109 (1985)401 109(1985) 173,289 109 (1985) 285 109(1985) 65 109 (1985) 389 109(1985) 73 109 (1985) 373 109(1985) 275 109 (1985) 81 109(1985) 395 109(1985) 81 109(1985) 355 109 (1985) 55,201 109(1985) 183 109(1985) 105 109 (1985) 97 109 (1985) 9 109(1985) 111 109(1985) 81 109 (1985)409 109(1985) 269, 349 109(1985) 65 109 (1985) 81 109 (1985) 105 109(1985) 19 109(1985) 363 109(1985)91,111,289 109(1985) 55 109(1985) 49 109(1985) 19 109(1985) 213 109(1985)413 109(1985) 229 109(1985) 213 109 (1985) 161, 335 109 (1985)201 109(1985) 173,263 109(1985)263 109(1985) 341 109(1985) 285
Chlorpromazine Chronic haloperidol Clone 235 - 1 Clonidine Classical neuroleptics Compound 48/'80 Conscious rats Convulsions Corpus striatum Cross tolerance CV-3988 CV-4151 Cyclic AMP Cyclic GMP
109 (1985) 193 109 (1985) 389 109 (1985) 335 109 (1985) 111 109 (1985) 81 109 (1985) 249 109 (1985) 9 109 (1985) 363 109 (1985) 417 109 (1985) 55 109 (1985) 257 109 (1985) 135 109 (1985) 335 109 (1985) 241
D-1 receptors 109 (1985) 269, 349 D-2 receptors 109 (1985) 269, 417 Dazoxiben 109 (1985) 117 Depression 109 (1985) 91 Diazepam 109 (1985) 241 Dihydro-fl-carboline 109 (1985) 363 Diuretic therapy 109 (1985) 401 DMSO 109 (1985) 213 Dobutamine 109 (1985) 173 Dogs 109 (1985) 49 Dopamine 109 (1985) 173, 341,355, 395, 417 Dopamine agonists 109 (1985) 229 Dopamine fl-hydroxylase inhibitors 109 (1985) 1 Dopamine metabolism 109 (1985) 229, 297 Dopamine receptor blockers 109 (1985) 269 Dopamine receptors 109 (1985) 297, 349, 389 Duodenal motility 109 (1985) 43 Electrical stimulation Electrochemistry (in vivo) Enantiomers Endotoxin shock Ethanol withdrawal Ethylketocylazocine
109(1985) 341 109(1985) 341 109(1985) 173 109 (1985) 257 109(1985) 321 109 (1985) 49
[3 H]Flunitrazepam binding Fluphenazine Fusaric acid
109(1985) 201 109(1985) 193 109(1985) 1
GABA Gastric Gastric Gastric Gastric Gastric
cytoprotection mucosal barrier mucosal defensive systems mucus ulcer
109 (1985) 19, 321 109 (1985) 145 109 (1985) 145 109 (1985) 145 109 (1985) 145 109 (1985) 145
456 GTP Guinea-pig lung Guinea-pigs
109(1985) 417 109(1985) 413 109(1985) 219,373
Harmalan Harmaline Heart failure Hematocrit Hemodynamics Hetrazepines 5-HIAA Hippocampal slices Histamine Hi-receptors 5-HT 5-HT uptake a-Human atrial natriuretic polypeptide (a-hANP) 6-Hydroxydopamine 3-(2-Hydroxyphenyl)cyclohexanols 5-Hydroxytryptamine release 5-Hydroxytryptophan (5-HTP) Hypertension Hypotension Hypovolemia
109(1985) 363 109(1985)241 109 (1985) 173, 405 109(1985) 249 109(1985) 173 109(1985) 19 109(1985) 381 109(1985) 395 109(1985) 249 !09 (1985) 381 109 (1985) 97 109(1985) 301,405 109(1985) 263 109 (1985) 201 109(1985) 395 109(1985) 409 109(1985) 111 109(1985) 301 109(1985) 249
Idazoxan lmidazole lmipramine Indoramin Infarct size Inositol phospholipids Intrarenal blood flow Iron deficiency Isoproterenol
109(1985) 153 109(1985) 117 109(1985) 97 109(1985) 9 109(1985) 117 109(1985) 293 109(1985) 301 109(1985) 193 109(1985)413
Ketanserin
109(1985) 363
Leukotriene C 4 Leukotriene D 4 Leukotriene E 4 Leukotriene receptors Levonantradol LSD binding Lung cells (momodispersed) Lung mast cells (purified) LY 171555 pergolide
109(1985) 183 109(1985) 183 109(1985) 183 109(1985) 183 109(1985) 201 109(1985)421 109(1985) 413 109(1985) 413 109(1985) 297
Magnesium Maitotoxin MAOI Median forebrain bundle Metabolism Methadone Methamphetamine Methyl-,8-carboline-3-carboxylate N-Methyl,N-propargyl-2-aminotetralins
109(1985)417 109(1985) 335 109(1985) 229,381 109(1985) 341 109(1985) 161 109(1985) 55 109(1985) 73 109 (1985)241 109(1985) 229
Metoclopramide Microtubules Monensin Morphine Muscarinic cholinergic agonists Muscarinic cholinergic receptors
109(1985) 81 109(1985) 161 109(1985) 161 109 (1985) 55 109(1985)293 109(1985) 161
Neurokinin A Neuropeptide Y Nifedipine [3H]NPA binding (in vitro) Nucleus tractus solitarii
109(1985) 109(1985) 109(1985) 109(1985) 109(1985)
Opiate receptor binding Opioid antagonists Opioid receptors x Opioid receptors Opioids
121 289 289 229 111
109(1985) 33 109(1985) 43 109(1985) 43,281 109(1985) 49 109(1985) 43
PAF-acether Pancreas Papillary muscles Paraventricular nucleus Parotid gland Pergolide PGI 2 Phencyclidine Physostigmine Pindolol Plasma extravasation Plasma renin activity Platelet activating factor (PAF) Platelets Postsynaptic [ 3H]Prazosin binding Preganglionic sympathetic nerve activity Presynaptic Progabide Prolactin Prolactin receptors Propranolol Purification
109(1985) 153 109(1985) 355 109 (1985) 321 109(1985) 193,335,409 109(1985) 193 109(1985) 117 109(1985) 97
Rat aorta Rat brain regions Rats Receptor regulation K Receptors Receptors Receptors (a, #, •, 8) Regional blood flow Release Repetitive firing Reserpine Reserpine reversal Ro 15-1788
109(1985) 275 109(1985) 421 109(1985) 105,173,405 109(1985) 183 109(1985) 281 109(1985) 281 109(1985) 33 109 (1985)301 109(1985) 381 109(1985) 213 109 (1985) 117, 381 109(1985) 229 109 (1985)241
109(1985) 219 109(1985) 293 109(1985) 219 109(1985) 9 109(1985) 355 109(1985) 349 109(1985) 135 109(1985) 33 109(1985) 91 109(1985) 65 109(1985) 249 109(1985) 249 109(1985) 257 109(1985) 91 109(1985) 355 109(1985) 285
457 Rotational behaviour SCH 23390 Sedation Serotonin Serotonin receptors SHR SKF 38393 Sleep Small intestinal motility Smooth muscle Smooth muscle relaxation Spiperone [ 3H]Spiperone Spontaneously hypertensive rats SRS-A Stereotypy Substance P Substance P antagonists Sulfonterol Sulpiride Supersensitivity Sympathetic transmission Sympathoexcitation Sympathomimetic effects Synaptic facilitation
109 (1985)349 109(1985) 269,349 109(1985) 269 109 (1985)91,409 109(1985) 421 109 (1985)301 109(1985) 297 109 (1985)269 109(1985 ) 49 109 (1985)161,327 109 (1985)275 109(1985)297 109 (1985) 417 109 (1985) 135 109 (1985) 183 109 (1985) 81,229 109(1985) 327 109(1985) 121 109(1985) 413 109(1985) 81 109(1985) 389 109(1985) 289 109(1985) 153 109(1985) 65 109(1985) 213
Tachykinins Taenia caeci Testosterone z~9-Tetrahydrocannabinol Thromboxane A 2 Thromboxane A 2 synthetase inhibitors Transmission Tryptamine
109(1985) 327 109(1985) 373 109 (1985) 193 109(1985)201 109 (1985) 135
U-50,488H Urinary bladder Uterus
109(1985) 49 109(1985) 327 109(1985) 65
Vasoactive intestinal polypeptide (VI P) Vasopressin
109(1985) 135 109(1985) 213 109 (1985)363
109 (1985)275,409 109 (1985) 111
WB 4101 Wy 26392
109(1985)285 109 (1985) 153
Yohimbine
109(1985) 153
Zinc salts
109(1985) 145